PHAXIAM Therapeutics S.A. Capital Reinvestment Ratio

Latest as of December 2012: 0.08x

PHAXIAM Therapeutics S.A. capital reinvestment ratio. PHAXIAM Therapeutics S.A. (PHXM) has a Capital Reinvestment Ratio of 0.08x as of December 2012, meaning it reinvests 0% of its operating cash flow (€621.40K) in capital expenditures (€48.40K). Check PHAXIAM Therapeutics S.A. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.08x

Capex / Operating Cash Flow

Operating Cash Flow

€621.40K

EUR

Capital Expenditures

€48.40K

EUR

Data as of

Dec 2012

Most recent filing

Capital Reinvestment Ratio of PHAXIAM Therapeutics S.A. (2012–2012)

Capital reinvestment ratio of PHAXIAM Therapeutics S.A. from 2012 to 2012. This chart tracks PHAXIAM Therapeutics S.A.'s Capital Reinvestment Ratio across 1 annual periods. Also explore PHAXIAM Therapeutics S.A. annual equity growth to track the company's year-over-year net asset growth rate.

PHAXIAM Therapeutics S.A. Capital Reinvestment Ratio by Year (2012–2012)

PHAXIAM Therapeutics S.A. capital reinvestment ratio by year from 2012 to 2012. For the full cash flow conversion analysis, see PHXM cash flow conversion.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change
2012	0.08x	€621.40K	€52.50K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow